Philip Lee
Equibles does not estimate personal net worth.
Get an email with a short summary when Senti Biosciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get SNTI alertsAbout Philip Lee
Philip Lee is recorded as CTO at Senti Biosciences Holdings, Inc. (SNTI). The newest filing on record that lists Philip Lee as CTO at Senti Biosciences Holdings, Inc. (SNTI) is dated May 1, 2023. Senti Biosciences Holdings, Inc. reported in an 8-K filed August 10, 2023 that Philip Lee resigned as Chief Technology Officer, effective August 7, 2023. Senti Biosciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Senti Biosciences Holdings, Inc. includes Timothy Lu (CEO and Board Member), Jay Cross (CFO), Timothy Lu, M.D., Ph.D. (CFO and Chief Accounting Officer) and 4 others.
“On August 7, 2023, Philip Lee, Ph.D., the Company's Chief Technology Officer, notified the Company of his resignation as an employee and as Chief Technology Officer of the Company, effective on August 7, 2023, to join GeneFab as its Chief Executive Officer.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 1, 2023
Company network
Leadership on record at Senti Biosciences Holdings, Inc.
- Timothy Lu CEO, Board Member
- Jay Cross CFO
- Timothy Lu, M.D., Ph.D. CFO, Chief Accounting Officer
- Yvonne Li Chief Accounting Officer
- Bryan Baum Board Member
- Feng Hsiung Board Member
- Fran Schulz Board Member